GlomCon Network
GlomCon Network is made and published by Glomerular Disease Study and Trial Consortium. AppBrain is an independent app data site and isn't affiliated with Glomerular Disease Study and Trial Consortium. The app name, icon, screenshots and description belong to Glomerular Disease Study and Trial Consortium and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- October 20, 2026
- Size
- 124.7 MB
It doesn't have enough ratings yet to judge what users think.
User feedback
Ratings and reviews on the App StoreComments on GlomCon Network for iOS
We don't have enough comments to show example comments. Please check back later.
Store listing
By Glomerular Disease Study and Trial Consortium, from the App Store
Description by Glomerular Disease Study and Trial Consortium Written by the developer, not by AppBrain. Click to read.
The GlomCon Network is a global kidney disease community providing peer support for patients, caregivers, and healthcare professionals to exchange experiences, share resources, discuss diagnostics and opportunities, and collaborate on a broad swath of initiatives, whether to raise awareness or initiate research projects.
THIS NETWORK IS ONLY FOR EDUCATIONAL ACTIVITIES AND PEER-TO-PEER SUPPORT.
PATIENTS AND CAREGIVERS WILL BE ABLE TO
Find a directory of Kidney Disease Experts in their community.
Exchange experience and resources with other patients and caregivers.
Find specialized clinics and disease experts globally.
Find available clinics and medical centers offering clinical trials.
Help members of the global community locate study sites and doctors who can discuss trial opportunities close to the patient.
Find updated information on various kidney diseases, such as:
IgA Nephropathy
FSGS (Focal Segmental Glomerulosclerosis)
Nephrotic Syndrome
Minimal Change Disease
(AMKD) APOL1 Mediated Kidney Disease
C3G (C3 Glomerulopathy)
Lupus nephritis
Alport syndrome
and many others
KIDNEY DISEASE EXPERTS WILL BE ABLE TO
Volunteer and create patient-centered medical education resources.
Answer general, not patient-specific, questions from the community that helps improve understanding of kidney diseases and the currently available treatment options.
Connect with each other and share experience and expertise in caring for patients with immune-mediated and complex kidney diseases.
Exchange ideas, innovate, and launch projects that can help improve the care of patients with kidney diseases.
NEPHROLOGY TRAINEES (RESIDENTS AND FELLOWS) WILL BE ABLE TO
Network with each other.
Share resources among each other.
Exchange work, general career, and other life experiences.
Network with nephrologists and nephropathologists across the globe.
Find mentors and participate in research or educational projects.
Learn from experts caring for patients with immune-mediated and complex kidney diseases.
Exchange ideas, innovate, and launch projects that can help improve the care of patients with kidney diseases.
WHAT THIS NETWORK IS NOT FOR:
Seek and solicit medical advice.
Obtain virtual care.
Store or share personal health information or medical records.
Give medical advice.
Safety and technology
Found in the app by AppBrain- Price
- Free
- App size
- 124.7 MB
- Content rating
- High
Technologies used by GlomCon Network
Releases
Updates seen on the App Store- Version
- 15.0.1
- Launched
- January 2023
No changelog data
Alternatives
Similar apps and more from Glomerular Disease Study and Trial ConsortiumAlternatives to GlomCon Network
Rankings
App Store top chartsApp Store Rankings for GlomCon Network
About the app and developer
About GlomCon Network
GlomCon Network is a social networking app developed by Glomerular Disease Study and Trial Consortium.
User Ratings
GlomCon Network is rated 5.00 out of 5 stars. The rating is based on one rating ratings.
App Information
GlomCon Network is freely available from the App Store. The app size is 124.67 MB. The latest version available is 15.0.1. The last update was on October 20, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since January 2023.